Announced details
Cancer whole-genome analysis; quality control in whole-genome analysis; practical implementation; transcriptome analysis
Cancer Precision Medicine Co., Ltd. (CPM) is our consolidated subsidiary. CPM is responsible for the research project.
Acros Fukuoka (Fukuoka City, Fukuoka Prefecture)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Ministry of Health, Labour and Welfare, "Plan for the Implementation of Whole Genome Analysis, etc."
| Item | Details |
|---|---|
| Names of Products / Services Covered | Cancer whole-genome analysis; transcriptome analysis |
| Counterparty | Annual Meeting of the Japanese Society for Genetic Medicine (33rd Annual Meeting) |
| Relationship with the Company | Cancer Precision Medicine Co., Ltd. (CPM) is our consolidated subsidiary. CPM is responsible for the research project. |
| Launch date | 10–11 July 2026 (scheduled presentation and conference dates) |
| Applicable area | Cancer whole-genome analysis; quality control in whole-genome analysis; practical implementation; transcriptome analysis |
| Location | Acros Fukuoka (Fukuoka City, Fukuoka Prefecture) |
| Source | Ministry of Health, Labour and Welfare, "Plan for the Implementation of Whole Genome Analysis, etc." |
Items this document does not state (11)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.CPM is responsible for cancer whole-genome analysis, transcriptome analysis and other activities under a research project based on the Ministry of Health, Labour and Welfare's "Plan for the Implementation of Whole Genome Analysis, etc."